NuVasive contends that Globus Medical’s LLIF lateral fusion offering — including instrumentation, implants and techniques under the trademarks of TransContinental, MARS 3V and LLIF — infringe on NuVasive’s XLIF intellectual property. The XLIF is a procedure for minimally invasive lumbar fusions.
Globus Medical has not responded to the NuVasive lawsuit.
Read the NuVasive release on patent infringement.
Read other coverage on NuVasive:
– Two Insurers Reverse Policies to Cover Procedures
– NuVasive Reports 2Q Revenue Up 35.2%
– Vail-Summit Spine Surgoen First to Use MAS-TLIF for Minimally Invasive Spine Fusion
